Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Early Stage Breast Cancer × Ciprofloxacin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Infections 7 Prostatic Neoplasms 5 Neutropenia 5 Neoplasms 5 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Leukemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Leukemia, Myeloid, Acute 3 Waldenstrom Macroglobulinemia 2 Urinary Tract Infections 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Intraocular Lymphoma 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Fever 2 Febrile Neutropenia 2

Interventions

Radiosurgery 3 Filgrastim 2 pegfilgrastim 1 Paclitaxel 1 DAT protocol 1 1 Ciprofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02816112 2020-05-27

REaCT-TC2

Ottawa Hospital Research Institute

Phase 4 Completed

Early Stage Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡